Concepedia

Yenima Martín‐Bauta

YM

Statistics

Publications

4

Citations

137

H-Index

4

Active since

2017

Affiliations

Centro de Ingeniería Genética y Biotecnología(Current)

Instituto de Cibernética Matemática y Física

Center of Molecular Immunology (Cuba)

Hospital Oncológico Docente "Conrado Benítez García"

Yenima Martín‐Bauta is an author at Centro de Ingeniería Genética y Biotecnología specializing in immunology, vaccination, and medicine.

ORCID

Top concepts

Publications per year

2017–2023

4

Publications

4

Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)

Francisco Hernández‐Bernal, Maria C. Ricardo-Cobas, Yenima Martín‐Bauta et al. · EClinicalMedicine · 2022 · 68 citations · Full text

, , +5

Specific humoral and cellular immune responses in cancer patients undergoing chronic immunization with a VEGF-based therapeutic vaccine

Yanelys Morera Díaz, Javier Sánchez Ramírez, Mónica Béquet‐Romero et al. · Vaccine · 2017 · 33 citations

, , +13

A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study)

Francisco Hernández‐Bernal, Maria C. Ricardo-Cobas, Yenima Martín‐Bauta et al. · The Lancet Regional Health - Americas · 2023 · 24 citations · Full text

Phase I Study of CIGB-300 AdministeredIntravenously in Patients with Relapsed/Refractory Solid Tumors

Noyde Batista-Albuerne, Lidia González-Méndez, Idrian García‐García et al. · 2018 · 12 citations

1–4 of 4